Qingdao Baheal Medical INC. (SHE:301015)
China
· Delayed Price · Currency is CNY 25.34
+1.21 (5.01%)
Apr 29, 2026, 3:04 PM CST
SHE:301015 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 12,683 | 12,405 | 12,725 | 18,830 | 12,518 | 15,911 | Upgrade
|
| Market Cap Growth | 15.29% | -2.52% | -32.42% | 50.42% | -21.32% | - | Upgrade
|
| Enterprise Value | 14,107 | 13,828 | 13,693 | 19,206 | 12,782 | 15,944 | Upgrade
|
| Last Close Price | 24.13 | 23.60 | 23.21 | 33.53 | 21.70 | 26.72 | Upgrade
|
| PE Ratio | 24.89 | 26.13 | 18.40 | 26.44 | 24.93 | 37.74 | Upgrade
|
| Forward PE | 14.11 | 16.50 | 13.27 | 25.05 | 21.53 | 33.48 | Upgrade
|
| PS Ratio | 1.67 | 1.65 | 1.57 | 2.28 | 1.67 | 2.26 | Upgrade
|
| PB Ratio | 4.59 | 4.52 | 4.89 | 6.04 | 5.49 | 7.32 | Upgrade
|
| P/TBV Ratio | 5.92 | 5.84 | 6.25 | 7.12 | 5.58 | 7.50 | Upgrade
|
| P/FCF Ratio | 22.32 | 19.22 | 24.96 | 30.67 | 62.46 | 103.45 | Upgrade
|
| P/OCF Ratio | 14.53 | 13.28 | 15.64 | 23.55 | 40.94 | 87.76 | Upgrade
|
| EV/Sales Ratio | 1.86 | 1.84 | 1.69 | 2.33 | 1.70 | 2.26 | Upgrade
|
| EV/EBITDA Ratio | 16.31 | 15.52 | 13.25 | 17.30 | 17.37 | 25.05 | Upgrade
|
| EV/EBIT Ratio | 17.74 | 17.18 | 13.95 | 18.25 | 17.94 | 25.94 | Upgrade
|
| EV/FCF Ratio | 24.82 | 21.42 | 26.86 | 31.28 | 63.77 | 103.66 | Upgrade
|
| Debt / Equity Ratio | 1.32 | 1.23 | 0.92 | 0.47 | 0.59 | 0.56 | Upgrade
|
| Debt / EBITDA Ratio | 4.27 | 3.79 | 2.26 | 1.28 | 1.74 | 1.87 | Upgrade
|
| Debt / FCF Ratio | 10.95 | 5.24 | 4.68 | 2.37 | 6.67 | 7.97 | Upgrade
|
| Net Debt / Equity Ratio | 0.37 | 0.36 | 0.34 | 0.03 | 0.12 | -0.04 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.20 | 1.10 | 0.84 | 0.07 | 0.36 | -0.14 | Upgrade
|
| Net Debt / FCF Ratio | 3.08 | 1.52 | 1.71 | 0.13 | 1.31 | -0.59 | Upgrade
|
| Asset Turnover | 0.94 | 0.99 | 1.20 | 1.44 | 1.56 | 1.64 | Upgrade
|
| Inventory Turnover | 4.80 | 5.15 | 5.84 | 7.28 | 8.52 | 8.55 | Upgrade
|
| Quick Ratio | 1.05 | 1.12 | 1.19 | 1.69 | 1.29 | 1.38 | Upgrade
|
| Current Ratio | 1.43 | 1.44 | 1.57 | 2.14 | 1.64 | 1.70 | Upgrade
|
| Return on Equity (ROE) | 22.01% | 21.39% | 26.80% | 28.55% | 21.80% | 22.60% | Upgrade
|
| Return on Assets (ROA) | 6.28% | 6.61% | 9.07% | 11.49% | 9.25% | 8.93% | Upgrade
|
| Return on Invested Capital (ROIC) | 16.57% | 17.70% | 23.33% | 27.47% | 22.37% | 23.81% | Upgrade
|
| Return on Capital Employed (ROCE) | 18.60% | 19.50% | 25.50% | 26.10% | 29.40% | 27.90% | Upgrade
|
| Earnings Yield | 4.16% | 3.83% | 5.44% | 3.78% | 4.01% | 2.65% | Upgrade
|
| FCF Yield | 4.48% | 5.20% | 4.01% | 3.26% | 1.60% | 0.97% | Upgrade
|
| Dividend Yield | 3.10% | - | 3.28% | - | 3.51% | 2.50% | Upgrade
|
| Payout Ratio | 78.60% | 98.50% | 65.05% | 61.81% | 80.11% | 13.22% | Upgrade
|
| Buyback Yield / Dilution | 0.31% | 1.29% | -0.92% | -2.37% | -5.44% | -5.50% | Upgrade
|
| Total Shareholder Return | 3.41% | 1.29% | 2.36% | -2.37% | -1.92% | -3.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.